News

Published on 6 Dec 2024 on Insider Monkey · via Yahoo Finance

Here’s Why Arbutus (ABUS) Surged in Q3

Article preview image

Tourlite Capital Management, an investment management firm, released its third quarter 2024 investor letter, a copy of which can be downloaded here....

Read the rest of the article
NASDAQ.ABUS price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Jim Cramer on Arbutus Biopharma Corporation (ABUS): ‘It Loses Money’

We recently compiled a list of the Jim Cramer’s Lightning Round: 7 Stocks Under the Spotlight. In...

Insider Monkey · via Yahoo Finance 16 Jan 2025
Here’s Why Arbutus (ABUS) Surged in Q3

Tourlite Capital Management, an investment management firm, released its third quarter 2024 inves...

Insider Monkey · via Yahoo Finance 6 Dec 2024
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q1 2024 Earnings Call Transcript

Arbutus Biopharma Corporation (NASDAQ:ABUS) Q1 2024 Earnings Call Transcript May 2, 2024 Arbutus ...

Insider Monkey via Yahoo Finance 4 May 2024
Arbutus Biopharma Corporation (NASDAQ:ABUS) Consensus Forecasts Have Become A Little Darker Since...

Arbutus Biopharma Corporation (NASDAQ:ABUS) shareholders are probably feeling a little disappoint...

Simply Wall St. via Yahoo Finance 3 Mar 2024
Analysts Just Made A Major Revision To Their Arbutus Biopharma Corporation (NASDAQ:ABUS) Revenue...

Today is shaping up negative for Arbutus Biopharma Corporation (NASDAQ:ABUS) shareholders, with t...

Simply Wall St. via Yahoo Finance 2 Mar 2024
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q4 2023 Earnings Call Transcript

Arbutus Biopharma Corporation (NASDAQ:ABUS) Q4 2023 Earnings Call Transcript February 29, 2024 Ar...

Insider Monkey via Yahoo Finance 1 Mar 2024
The past three years for Arbutus Biopharma (NASDAQ:ABUS) investors has not been profitable

Arbutus Biopharma Corporation (NASDAQ:ABUS) shareholders should be happy to see the share price u...

Simply Wall St. via Yahoo Finance 31 Jan 2024
Institutions own 30% of Arbutus Biopharma Corporation (NASDAQ:ABUS) shares but individual investors...

Key Insights Significant control over Arbutus Biopharma by individual investors implies that the ...

Simply Wall St. via Yahoo Finance 1 Jan 2024
Analysts Are Betting On Arbutus Biopharma Corporation (NASDAQ:ABUS) With A Big Upgrade This Week

Celebrations may be in order for Arbutus Biopharma Corporation (NASDAQ:ABUS) shareholders, with t...

Simply Wall St. via Yahoo Finance 9 Nov 2023
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q3 2023 Earnings Call Transcript

Arbutus Biopharma Corporation (NASDAQ:ABUS) Q3 2023 Earnings Call Transcript November 7, 2023 Arb...

Insider Monkey via Yahoo Finance 9 Nov 2023

Copyright Statfolio @ 2025

Social Accounts